Emergence of VanD-type vancomycin-resistant Enterococcus faecium in Stockholm, Sweden

被引：6

作者：

Fang, H. ^{[1
]}

Hedin, G. ^{[1
]}

Telander, B. ^{[1
]}

Li, G. ^{[1
]}

Nord, C. E. ^{[1
]}

机构：

[1] Karolinska Univ Hosp, Div Clin Bacteriol, Dept Lab Med, Karolinska Inst, SE-14186 Stockholm, Sweden

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2007年 / 13卷 / 01期

关键词：

Enterococcus faecium; resistance; Sweden; teicoplanin; vancomycin; vanD;

D O I：

10.1111/j.1469-0691.2006.01569.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

A vancomycin-resistant Enterococcus faecium isolate from the urine of a liver transplant patient in Stockholm was found to contain a vanD gene. The sequence of the vanD PCR product shared 100% identity with the vanD5 allele. The isolate was resistant to a relatively high level of vancomycin (128 mg/L) and a low level of teicoplanin (4 mg/L). This is the first VanD-type vancomycin-resistant E. faecium isolate reported in Sweden. The emergence of this strain reinforces the necessity of infection control efforts to interrupt the spread of these organisms.

引用

收藏

页码：106 / 108

页数：4

相关论文

共 17 条

[1] Glycopeptide resistance in enterococci [J].

Arthur, M ;

Reynolds, P ;

Courvalin, P .

TRENDS IN MICROBIOLOGY, 1996, 4 (10) :401-407

[2] Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant:: characterization of the VanD5 operon [J].

Boyd, DA ;

Kibsey, P ;

Roscoe, D ;

Mulvey, MR .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (03) :680-683

[3] Vancomycin resistance in gram-positive cocci [J].

Courvalin, P .

CLINICAL INFECTIOUS DISEASES, 2006, 42 :S25-S34

[4] Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil [J].

Dalla Costa, LM ;

Reynolds, PE ;

Souza, HAPHM ;

Souza, DC ;

Palepou, MFI ;

Woodford, N .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3444-3446

[5] Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR [J].

Depardieu, F ;

Perichon, B ;

Courvalin, P .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (12) :5857-5860

[6] VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis [J].

Depardieu, F ;

Kolbert, M ;

Pruul, H ;

Bell, J ;

Courvalin, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3892-3904

[7] VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405 [J].

Fines, M ;

Perichon, B ;

Reynolds, P ;

Sahm, DF ;

Courvalin, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2161-2164

[8] First infection with VanD-Type glycopeptide-resistant Enterococcus faecium in Europe [J].

Lavigne, JP ;

Marchandin, H ;

Bouziges, N ;

Sotto, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (07) :3512-3515

[9] PLASMID-MEDIATED RESISTANCE TO VANCOMYCIN AND TEICOPLANIN IN ENTEROCOCCUS-FAECIUM [J].

LECLERCQ, R ;

DERLOT, E ;

DUVAL, J ;

COURVALIN, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (03) :157-161

[10] Vancomycin: A history [J].

Levine, DP .

CLINICAL INFECTIOUS DISEASES, 2006, 42 :S5-S12